Looking forward to the presentation and discussion. #LBA1 Phase 3 INTerpath-001 trial results at #ESMO26 👉🏽The Kaplan-Meir curves don’t always tell the whole story. Side effects, cost, access matter but 👉🏽Its is very exciting that a personalized mRNA technology can be used to control cancer recurrence.